4.5 Article

Thrombocytopenia and platelet count recovery in patients with sepsis-3: a retrospective observational study

期刊

PLATELETS
卷 33, 期 4, 页码 612-620

出版社

TAYLOR & FRANCIS INC
DOI: 10.1080/09537104.2021.1970124

关键词

Mortality; multiple organ dysfunction syndrome; platelet recovery; sepsis-3; thrombocytopenia

资金

  1. National Natural Science Foundation of China [82002088]
  2. President Foundation of Nanfang Hospital, Southern Medical University [2019Z021]

向作者/读者索取更多资源

Thrombocytopenia is common in critical illness, with 18% of Sepsis-3 patients affected. Platelet recovery was more frequent and occurred earlier in survivors, and was not observed until clinical improvement. Thrombocytopenia in Sepsis-3 demonstrated increased disease severity, and patients with platelet count <50 x 10(9)/L showed increased 28 days mortality.
Thrombocytopenia is common in critical illness. But there are no studies that focus on thrombocytopenia and platelet recovery in Sepsis-3 patients. We employed a large database to identify sepsis based on Sepsis-3 criteria. Patients were grouped by nadir platelet count during ICU, propensity score matching was used to eliminate covariates imbalance, multivariable cox proportional hazard model was used for evaluating mortality. A total of 9709 patients were enrolled based on Sepsis-3, 1794 (18%) patients developed thrombocytopenia, with 858 (8.8%) exhibiting thrombocytopenia at ICU admission (prevalent), 891 (9.2%) developed thrombocytopenia during ICU stay (incident). In the incident thrombocytopenia group, survivors exhibited higher nadir platelet count, higher rate in platelet count recovery and shorter time to platelet recovery compared to non-survivors. Platelet recovery was not observed until 1 days (IQR, 1-2) after weaning of mechanical ventilation and 1 days (IQR, 1-3) after discontinuation of vasopressor in survivors of incident thrombocytopenia. Furthermore, thrombocytopenia was associated with longer duration of ICU length of stay, longer duration of mechanical ventilation and vasopressor use compared to no thrombocytopenia. Moderate (20-50 x 10(9)/L) and severe (<20 x 10(9)/L) thrombocytopenia group showed increased 28 days mortality compared to no thrombocytopenia, while the mortality rate between mild (51-100 x 10(9)/L) and no thrombocytopenia group (>= 100 x 10(9)/L) showed no significant difference. Taken together these data revealed that thrombocytopenia occurred in 18% Sepsis-3 patients; platelet recovery occurred more frequent and earlier in survivors; platelet recovery was not observed until clinical improvement. Thrombocytopenia in Sepsis-3 demonstrated increased disease severity, and patients with platelet count <50 x 10(9)/L showed increased 28 days mortality.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据